28276968|t|Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease
28276968|a|Local myocardial delivery (LMD) of therapeutic agents is a promising strategy that aims to treat various myocardial pathologies. It is designed to deliver agents directly to the myocardium and minimize their extracardiac concentrations and side effects. LMD aims to enhance outcomes of existing therapies by broadening their therapeutic window and to utilize new agents that could not be otherwise be implemented systemically. Areas covered: This article provides a historical overview of six decades LMD evolution in terms of the approaches, including intrapericardial, epicardial, and intramyocardial delivery, and the wide array of classes of agents used to treat myocardial pathologies. We examine delivery of pharmaceutical compounds, targeted gene transfection and cell implantation techniques to produce therapeutic effects locally. We outline therapeutic indications, successes and failures as well as technical approaches for LMD. Expert opinion: While LMD is more complicated than conventional oral or intravenous administration, given recent advances in interventional cardiology, it is safe and may provide better therapeutic outcomes. LMD is complex as many factors impact pharmacokinetics and biologic result. The choice between routes of LMD is largely driven not only by the myocardial pathology but also by the nature and physicochemical properties of the therapeutic agents.
28276968	0	8	Delivery	T169	C1705822
28276968	12	17	drugs	T121	C0013227
28276968	19	33	growth factors	T116,T123	C0018284
28276968	35	40	genes	T028	C0017337
28276968	45	55	stem cells	T025	C0038250
28276968	60	76	intrapericardial	T169	C2960799
28276968	78	88	epicardial	T082	C0442016
28276968	93	108	intramyocardial	T030	C0229984
28276968	109	115	routes	T169	C0013153
28276968	120	129	sustained	T169	C0443318
28276968	130	135	local	T082	C0205276
28276968	136	152	targeted therapy	T061	C2985566
28276968	156	174	myocardial disease	T047	C0878544
28276968	175	200	Local myocardial delivery	T061	C0087111
28276968	202	205	LMD	T061	C0087111
28276968	210	228	therapeutic agents	T121	C1611640
28276968	266	271	treat	T169	C1522326
28276968	280	290	myocardial	T082	C1522564
28276968	291	302	pathologies	T169	C1521733
28276968	310	318	designed	T052	C1707689
28276968	322	329	deliver	T169	C1705822
28276968	330	336	agents	T121	C1611640
28276968	337	345	directly	T080	C1947931
28276968	353	363	myocardium	T024	C0027061
28276968	368	376	minimize	T052	C2003888
28276968	383	395	extracardiac	T030	C0229984
28276968	396	410	concentrations	T081	C0678756
28276968	415	427	side effects	T046	C0041755
28276968	429	432	LMD	T061	C0087111
28276968	441	448	enhance	T052	C2349975
28276968	449	457	outcomes	T080	C0085415
28276968	470	479	therapies	T061	C0087111
28276968	500	511	therapeutic	T169	C0302350
28276968	538	544	agents	T121	C1611640
28276968	576	587	implemented	T052	C1705848
28276968	588	600	systemically	T169	C0205373
28276968	622	629	article	T170	C0282420
28276968	641	660	historical overview	T170	C0681456
28276968	664	667	six	T081	C0205452
28276968	668	675	decades	T079	C1254367
28276968	676	679	LMD	T061	C0087111
28276968	706	716	approaches	T169	C1292724
28276968	728	744	intrapericardial	T169	C2960799
28276968	746	756	epicardial	T082	C0442016
28276968	762	777	intramyocardial	T030	C0229984
28276968	778	786	delivery	T169	C1705822
28276968	810	817	classes	T170	C0456387
28276968	821	827	agents	T121	C1611640
28276968	836	841	treat	T169	C1522326
28276968	842	852	myocardial	T082	C1522564
28276968	853	864	pathologies	T169	C1521733
28276968	877	885	delivery	T169	C1705822
28276968	889	913	pharmaceutical compounds	T121	C0013227
28276968	915	941	targeted gene transfection	T063	C0040669
28276968	946	974	cell implantation techniques	T061	C0087111
28276968	986	997	therapeutic	T169	C0302350
28276968	998	1005	effects	T080	C1280500
28276968	1006	1013	locally	T082	C0205276
28276968	1026	1037	therapeutic	T169	C0302350
28276968	1051	1060	successes	T080	C0679864
28276968	1065	1073	failures	T033	C0162643
28276968	1085	1105	technical approaches	T169	C1292724
28276968	1110	1113	LMD	T061	C0087111
28276968	1137	1140	LMD	T061	C0087111
28276968	1149	1160	complicated	T169	C0231242
28276968	1166	1178	conventional	T080	C1442989
28276968	1179	1183	oral	T169	C1527415
28276968	1187	1213	intravenous administration	T169	C1522726
28276968	1221	1227	recent	T079	C0332185
28276968	1240	1265	interventional cardiology	T091	C4298931
28276968	1301	1321	therapeutic outcomes	T080	C0085415
28276968	1323	1326	LMD	T061	C0087111
28276968	1330	1337	complex	T080	C0439855
28276968	1346	1353	factors	T169	C1521761
28276968	1361	1377	pharmacokinetics	T039	C0031327
28276968	1382	1390	biologic	T080	C0205460
28276968	1391	1397	result	T169	C1274040
28276968	1418	1424	routes	T169	C0013153
28276968	1428	1431	LMD	T061	C0087111
28276968	1466	1476	myocardial	T082	C1522564
28276968	1477	1486	pathology	T169	C1521733
28276968	1514	1540	physicochemical properties	T070	C2350461
28276968	1548	1566	therapeutic agents	T121	C1611640